Skip to main content
SpringerLink
Log in

Diätetische Behandlung der Hyperlipoproteinämien

  • Conference paper
Aktuelle Gesichtspunkte der Hyperlipoproteinämien

  • 14 Accesses

Zusammenfassung

Die Ernährungstherapie ist die Grundlage der Behandlung von Hyperlipoproteinämien. Es besteht kein Zweifel daran, daß die Zusammensetzung und die Menge der aufgenommenen Nahrung die Konzentrationen der Lipide im Serum des Gesunden beeinflussen. Bei Patienten mit angeborenen Lipoproteinstoffwechselstörungen werden durch eine ungünstige Ernährung die unterschiedlichen, aber charakteristischen Veränderungen des Lipoproteinmusters im Serum noch verstärkt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Beynen AC, Katan MB, van Zutphen FM (1985) Individuelle Unterschiede der Serumcholesterinreaktion auf Änderungen der Ernährungsform. Ernähr-Umsch 32: 356–360

    Google Scholar 

  2. Connor WE, Witiak DT, Stone DB, Armstrong ML (1969) Cholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition. J clin Invest 48: 1363–1375

    Article  PubMed  CAS  Google Scholar 

  3. Goodnight SH, Harris WS, Connor WE, Illingworth DR (1982) Polyunsaturated fatty acids, hyperlipidemia and thrombosis. Arteriosclerosis 2: 87–113

    Article  PubMed  CAS  Google Scholar 

  4. Harris WS, Dujovne CA, Zucker ML, Johnson BE (1987) Fish oil Supplements raise low density lipoprotein cholesterol levels in hypertriglyceridemic patients. Circulation 76: Supp. IV 168

    Google Scholar 

  5. Hegsted DM, McGandy RD, Myers ML, Stare FJ (1965) Quantitative effects of dietary fat on serum cholesterol in man. A J Clin Nutr 17: 281–295

    CAS  Google Scholar 

  6. Hoover RL, Karnovsky MJ, Austen KF, Corey E, Lewis RA (1984) Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci USA 81: 2191–2193

    Article  PubMed  CAS  Google Scholar 

  7. Hulley S, Ashman P, Kuller L, Lasser N, Sherwin R (1979) HDL-Cholesterol levels in the multiple risk factor intervention trial (MRFIT). By the MRFIT research group. Lipids 14: 119–125

    Google Scholar 

  8. Huttunen JK, Ehnholm C, Kekki M, Nikkilä EA (1976) Postheparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci molec Med 50: 249–260

    CAS  Google Scholar 

  9. Kaffarnik H, Schneider J (1976) Die äthanolinduzierte Hyperlipoproteinämie der stoffwechselgesunden Menschen. Klin Wochenschr 54: 747–754

    Article  PubMed  CAS  Google Scholar 

  10. Keys A, Anderson JT, Grande S (1965) Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism 14: 776–787

    Google Scholar 

  11. Kreisberg RA, Kasim S (1987) Cholesterol metabolism and aging. Am J Med 82: Suppl 1B, 54–60

    Google Scholar 

  12. Leeharthaepin B, Woodhill JM, Palmer AJ, Blacket RB (1974) Obesity diet, and Type II Hyperlipidemia. Lancet II: 1217–1221

    Google Scholar 

  13. Lees RS, Fredrickson DS (1965) Carbohydrate induction of hyperlipemia in normal man. Clin Res 13: 327

    Google Scholar 

  14. Lehtonen A, Viikari J (1978) Serum triglycerides and cholesterol and serum high density lipoprotein cholesterol in highly physically active men. Acta med Scand 204: 111–114

    Article  PubMed  CAS  Google Scholar 

  15. Lewis B, Katan M, Merkx I, Miller NE, Hammett F, Kay RM, Nobels A, Swan AV (1981) Towards an improved lipid-lowering diet: Additive effects of changes in nutrient intake. Lancet II: 1310–1313

    Google Scholar 

  16. Mattson FH, Erickson BA, Kligman AM (1972) Effect of dietary cholesterol on serum cholesterol in man. Amer J Clin Nutr 25: 589–594

    PubMed  CAS  Google Scholar 

  17. McNamara D, Kolb R, Parker DS, Batwin H, Samuel P, Brown CD, Ahrens EH (1987) Heterogeneity of cholesterol homeostasis in man. J Clin Invest 79: 1729–1739

    Article  PubMed  CAS  Google Scholar 

  18. Miller NE (1984) Why does plasma low density lipoprotein concentration in adults increase with age? Lancet I: 263–267

    Google Scholar 

  19. Mistry P, Miller E, Laker E, Hazzard WR, Lewis B (1981) Individual variation on plasma lipoproteins and cellular cholesterol homeostasis in man. J Clin Invest 67: 493–502

    Article  PubMed  CAS  Google Scholar 

  20. Needleman P, Raz A, Minkes MS et al (1979) Triene prostaglandins: prostacyclin and thrombo-xane biosynthesis and unique biologic properties. Proc Natl Acad Sci USA 76: 944–948

    Article  PubMed  CAS  Google Scholar 

  21. Schlierf G, Reinheimer W, Stossberg V (1971) Diurnal patterns of plasma triglycerides and free fatty acids in normal subjects and in patients with endogenous ( Type IV) hyperlipoproteinemia. Nutr Metabol 13: 80–91

    Google Scholar 

  22. Schlierf G, Wolfram G (1977) Bedeutung des Fettes als krankmachender Faktor in der Ernährung. Internist 18: 480–484

    PubMed  CAS  Google Scholar 

  23. Streja DA, Boyko E, Rabkin SW (1980) Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects. Brit Med J 281: 770–772

    Article  PubMed  CAS  Google Scholar 

  24. Taskinen MR, Nikkilä E (1977) Nocturnal hypertriglyceridemia and hyperinsulinaemia following moderate evening intake of alcohol. Acta Med Scand 202: 173–177

    Article  PubMed  CAS  Google Scholar 

  25. Wolfram G (1981) Ernährungstherapie der Hyperlipidämien. Akt Endokrin 2: 7–15

    Google Scholar 

  26. Wolfram G (1987) Metabolische Wirkungen linolsäurereicher Kost. Akt Ernähr 12: 11–19

    CAS  Google Scholar 

  27. Wolfram G (1985) Hyperlipoproteinämien in: Stoffwechselkrankheiten, Hrsg. Mehnert H, Thieme Verlag Stuttgart

    Google Scholar 

Download references

Authors
  1. G. Wolfram
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abtl. Endokrinologie u. Stoffwechsel Zentrum Innere Medizin, Universität Marburg, Baldinger Straße, D-3550, Marburg, Germany

    Hans Kaffarnik , Jürgen Schneider  & Armin Steinmetz ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wolfram, G. (1988). Diätetische Behandlung der Hyperlipoproteinämien. In: Kaffarnik, H., Schneider, J., Steinmetz, A. (eds) Aktuelle Gesichtspunkte der Hyperlipoproteinämien. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73478-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73478-6_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19023-3

  • Online ISBN: 978-3-642-73478-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation